BlackRock Health Sciences Trust Stock

Equities

BME

US09250W1071

Closed End Funds

Market Closed - Nyse 04:10:00 2024-04-15 pm EDT 5-day change 1st Jan Change
38.51 USD +0.16% Intraday chart for BlackRock Health Sciences Trust -3.39% -4.82%
Sales 2022 7.73M Sales 2023 8.19M Capitalization 508M
Net income 2022 -26M Net income 2023 20M EV / Sales 2022 70.9 x
Net Debt 2022 676K Net Debt 2023 60.15K EV / Sales 2023 62.1 x
P/E ratio 2022
-22.8 x
P/E ratio 2023
28.2 x
Employees -
Yield 2022
5.87%
Yield 2023
6.32%
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
BlackRock Health Sciences Trust Reports Earnings Results for the Full Year Ended December 31, 2023 CI
BlackRock Health Sciences Trust's Equity Buyback announced on September 8, 2022 has expired. CI
BlackRock Health Sciences Trust announces an Equity Buyback for repurchase of its own shares, representing 5% of its issued share capital. CI
BlackRock Health Sciences Trust authorizes a Buyback Plan. CI
BlackRock Health Sciences Trust Reports Earnings Results for the Half Year Ended June 30, 2023 CI
BlackRock Health Sciences Trust Reports Earnings Results for the Full Year Ended December 31, 2022 CI
BlackRock Advisors, LLC announces an Equity Buyback for up to 5% of its outstanding common shares. CI
BlackRock Advisors, LLC announces an Equity Buyback for up to 5% of its outstanding common shares. CI
BlackRock Advisors, LLC announces an Equity Buyback for up to 5% of its outstanding common shares. CI
BlackRock Advisors, LLC announces an Equity Buyback for up to 5% of its outstanding common shares. CI
BlackRock Advisors, LLC announces an Equity Buyback for up to 5% of its outstanding common shares. CI
BlackRock Advisors, LLC announces an Equity Buyback for up to 5% of its outstanding common shares. CI
BlackRock Health Sciences Trust authorizes a Buyback Plan. CI
BlackRock Health Sciences Trust announces an Equity Buyback for repurchase up to 5% of its outstanding common shares. CI
BlackRock Health Sciences Trust II authorizes a Buyback Plan. CI
More news
1 day+0.16%
1 week-3.39%
Current month-7.07%
1 month-6.44%
3 months-9.60%
6 months+0.13%
Current year-4.82%
More quotes
1 week
38.43
Extreme 38.43
39.86
1 month
38.43
Extreme 38.43
41.74
Current year
38.43
Extreme 38.43
42.86
1 year
35.53
Extreme 35.53
43.20
3 years
35.53
Extreme 35.53
49.98
5 years
27.00
Extreme 27
50.94
10 years
27.00
Extreme 27
50.94
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 10-12-31
Director of Finance/CFO 50 20-12-31
Compliance Officer 57 13-12-31
Members of the board TitleAgeSince
Director/Board Member 76 06-12-31
Director/Board Member 73 06-12-31
Chief Executive Officer 60 10-12-31
More insiders
Date Price Change Volume
24-04-15 38.51 +0.16% 49,960
24-04-12 38.45 -2.39% 43,129
24-04-11 39.39 -0.56% 29,831
24-04-10 39.61 -0.98% 24,744
24-04-09 40 +0.35% 31,798

Delayed Quote Nyse, April 15, 2024 at 04:10 pm EDT

More quotes
BlackRock Health Sciences Trust (the Trust) is a closed-end management investment company. The Trust investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, approximately 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry. The Trust is focused on achieving its goal primarily by investing in a portfolio of equity securities and also by employing a strategy of writing (selling) call and put options. The Trust invests in a portfolio of sectors, which include biotechnology, health care equipment and supplies, life sciences tools and services, and pharmaceuticals. BlackRock Advisors, LLC acts as the manager of the Trust.
More about the company